Cooper Companies Upgraded to 'Buy' Rating

Wall Street Zen cites strong performance and growth potential in raising its recommendation on the medical device company's stock.

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Investment analysts at Wall Street Zen have upgraded Cooper Companies (NASDAQ:COO) from a 'hold' rating to a 'buy' rating in a research note issued on Saturday. The analysts cited the company's strong financial performance and growth potential as reasons for the upgrade.

Why it matters

The upgrade from Wall Street Zen is a positive sign for Cooper Companies, a global medical device company that operates in the vision care and women's health markets. The improved rating could boost investor confidence and potentially drive up the stock price.

The details

In their research note, the analysts at Wall Street Zen noted that Cooper Companies has seen its share price rise in recent months, with the stock trading at around $83.67 as of Friday's market close. The company has a market capitalization of $16.32 billion and a price-to-earnings ratio of 44.51.

  • Wall Street Zen issued the upgrade on Saturday, February 28, 2026.

The players

Cooper Companies

A global medical device company headquartered in San Ramon, California that develops, manufactures, and markets a range of vision care and women's health products.

Wall Street Zen

An investment research firm that provides analysis and recommendations on publicly traded companies.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The upgrade from Wall Street Zen is a positive development for Cooper Companies, as it signals the firm's confidence in the company's ability to continue its strong performance and growth trajectory in the medical device market.